These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7903467

  • 1. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
    Molchan SE, Hill JL, Martinez RA, Lawlor BA, Mellow AM, Rubinow DR, Bissette G, Nemeroff CB, Sunderland T.
    Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
    Banki CM, Karmacsi L, Bissette G, Nemeroff CB.
    J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
    [Abstract] [Full Text] [Related]

  • 3. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.
    Molchan SE, Hill JL, Mellow AM, Lawlor BA, Martinez R, Sunderland T.
    Int Psychogeriatr; 1990 May; 2(2):99-122. PubMed ID: 1713799
    [Abstract] [Full Text] [Related]

  • 4. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE, Lawlor BA, Hill JL, Martinez RA, Davis CL, Mellow AM, Rubinow DR, Sunderland T.
    Biol Psychiatry; 1991 Jun 01; 29(11):1110-8. PubMed ID: 1714776
    [Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW.
    Neuroendocrinology; 1993 Jan 01; 57(1):79-88. PubMed ID: 8097579
    [Abstract] [Full Text] [Related]

  • 6. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
    Doran AR, Rubinow DR, Roy A, Pickar D.
    Arch Gen Psychiatry; 1986 Apr 01; 43(4):365-9. PubMed ID: 2869743
    [Abstract] [Full Text] [Related]

  • 7. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B.
    Br J Psychiatry; 1996 Jun 01; 168(6):679-87. PubMed ID: 8773809
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F.
    Depress Anxiety; 1998 Jun 01; 8(2):71-9. PubMed ID: 9784981
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J, Wolfsgruber S, Heuser I, Peters O, Hüll M, Schröder J, Möller HJ, Lewczuk P, Schneider A, Jahn H, Luckhaus C, Perneczky R, Frölich L, Wagner M, Maier W, Wiltfang J, Kornhuber J, Jessen F.
    Neurobiol Aging; 2015 Feb 01; 36(2):601-7. PubMed ID: 25435336
    [Abstract] [Full Text] [Related]

  • 10. Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression.
    Hoogendijk WJ, Meynen G, Endert E, Hofman MA, Swaab DF.
    Neurobiol Aging; 2006 May 01; 27(5):780.e1-780.e2. PubMed ID: 16198445
    [Abstract] [Full Text] [Related]

  • 11. Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.
    Martignoni E, Petraglia F, Costa A, Bono G, Genazzani AR, Nappi G.
    Acta Neurol Scand; 1990 May 01; 81(5):452-6. PubMed ID: 2375247
    [Abstract] [Full Text] [Related]

  • 12. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
    Sunderland T, Rubinow DR, Tariot PN, Cohen RM, Newhouse PA, Mellow AM, Mueller EA, Murphy DL.
    Am J Psychiatry; 1987 Oct 01; 144(10):1313-6. PubMed ID: 2889377
    [Abstract] [Full Text] [Related]

  • 13. Endocrine changes in Alzheimer's disease.
    Davidson M, Bastiaens L, Davis BM, Shah MB, Davis KL.
    Neurol Clin; 1988 Feb 01; 6(1):149-57. PubMed ID: 2898094
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type.
    Martignoni E, Petraglia F, Costa A, Monzani A, Genazzani AR, Nappi G.
    J Clin Lab Anal; 1990 Feb 01; 4(1):5-8. PubMed ID: 2313466
    [Abstract] [Full Text] [Related]

  • 15. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.
    Widerlöv E, Bissette G, Nemeroff CB.
    J Affect Disord; 1988 Feb 01; 14(2):99-107. PubMed ID: 2452842
    [Abstract] [Full Text] [Related]

  • 16. The function of the hypothalamic-pituitary-adrenal axis in Alzheimer's disease. Response to insulin hypoglycaemia.
    O'Brien JT, Schweitzer I, Ames D, Mastwyk M, Colman P.
    Br J Psychiatry; 1994 Nov 01; 165(5):650-7. PubMed ID: 7866680
    [Abstract] [Full Text] [Related]

  • 17. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB.
    Am J Psychiatry; 1987 Jul 01; 144(7):873-7. PubMed ID: 3496802
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression.
    Roy A.
    Biol Psychiatry; 1992 Nov 01; 32(9):812-6. PubMed ID: 1450295
    [Abstract] [Full Text] [Related]

  • 19. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
    Meador-Woodruff JH, Greden JF, Grunhaus L, Haskett RF.
    Acta Psychiatr Scand; 1990 Apr 01; 81(4):364-71. PubMed ID: 2343764
    [Abstract] [Full Text] [Related]

  • 20. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL, Nemeroff CB.
    Br J Psychiatry Suppl; 1996 Jun 01; (30):123-8. PubMed ID: 8864158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.